speb/financial-data huggingface dataset:
MME.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 91276000.00
MME.AX balance_sheet (annual, 2022-06-30) — Current Assets: 1354962000.00
MME.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 1038000.00
MME.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 1038000.00
MME.AX balance_sheet (annual, 2022-06-30) — Current Deferred Assets: 13000.00
MME.AX balance_sheet (annual, 2022-06-30) — Current Deferred Taxes Assets: 13000.00
MME.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 20623000.00
MME.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 2239000.00
MME.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 2239000.00
MME.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 1133000.00
MME.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 190801578.00
MME.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.26
MME.AX income_statement (annual, 2022-06-30) — EBIT: -9379000.00
MME.AX income_statement (annual, 2022-06-30) — EBITDA: -7140000.00
MME.AX cash_flow (annual, 2022-06-30) — End Cash Position: 80675000.00
MME.AX balance_sheet (annual, 2022-06-30) — Financial Assets: 10486000.00
MME.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 664418000.00
MME.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: 75323000.00
MME.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 4529000.00
MME.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 28162000.00
MME.AX balance_sheet (annual, 2022-06-30) — Goodwill: 63510000.00
MME.AX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 99563000.00
MME.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 3880000.00
MME.AX income_statement (annual, 2022-06-30) — Gross Profit: 127784000.00
MME.AX balance_sheet (annual, 2022-06-30) — Hedging Assets Current: 10486000.00
MME.AX income_statement (annual, 2022-06-30) — Interest Expense: 38403000.00
MME.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 38403000.00
MME.AX cash_flow (annual, 2022-06-30) — Interest Paid Cff: -29266000.00
MME.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 23000.00
MME.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 1449547000.00
MME.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -689085000.00
MME.AX cash_flow (annual, 2022-06-30) — Issuance Of Debt: 704956000.00
MME.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 1624000.00
MME.AX balance_sheet (annual, 2022-06-30) — Long Term Debt: 1358271000.00
MME.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 1359895000.00
MME.AX cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 704956000.00
MME.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 1380000.00
MME.AX balance_sheet (annual, 2022-06-30) — Net Debt: 1277596000.00
MME.AX income_statement (annual, 2022-06-30) — Net Income: -50364000.00
MME.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -50364000.00
MME.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -50364000.00
MME.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -50364000.00
MME.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -50364000.00
MME.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -50364000.00
MME.AX cash_flow (annual, 2022-06-30) — Net Intangibles Purchase And Sale: -3506000.00
MME.AX income_statement (annual, 2022-06-30) — Net Interest Income: -38493000.00
MME.AX cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: -14524000.00
MME.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: 704956000.00
MME.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: 704956000.00
MME.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -38493000.00
MME.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -12084000.00
MME.AX cash_flow (annual, 2022-06-30) — Net Other Investing Changes: -685230000.00
MME.AX balance_sheet (annual, 2022-06-30) — Net PPE: 2066000.00
MME.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -349000.00
MME.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: -8287000.00
MME.AX balance_sheet (annual, 2022-06-30) — Non Current Accounts Receivable: 10197000.00
MME.AX balance_sheet (annual, 2022-06-30) — Non Current Deferred Assets: 3192000.00
MME.AX balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Assets: 3192000.00
MME.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -7140000.00
MME.AX income_statement (annual, 2022-06-30) — Normalized Income: -50364000.00
MME.AX income_statement (annual, 2022-06-30) — Operating Income: -24578000.00
MME.AX income_statement (annual, 2022-06-30) — Operating Revenue: 127784000.00
MME.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 235847226.00
MME.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: 14173000.00
MME.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 4529000.00
MME.AX income_statement (annual, 2022-06-30) — Other Gand A: 28162000.00
MME.AX income_statement (annual, 2022-06-30) — Other Income Expense: 15289000.00
MME.AX balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 36053000.00
MME.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 15289000.00
MME.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 8914000.00
MME.AX balance_sheet (annual, 2022-06-30) — Other Payable: 15461000.00
MME.AX balance_sheet (annual, 2022-06-30) — Other Properties: 2500000.00
MME.AX balance_sheet (annual, 2022-06-30) — Payables: 15461000.00
MME.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 15461000.00
MME.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -51000000.00
MME.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 4124000.00
MME.AX income_statement (annual, 2022-06-30) — Pretax Income: -47782000.00
MME.AX income_statement (annual, 2022-06-30) — Provision For Doubtful Accounts: 91018000.00
MME.AX cash_flow (annual, 2022-06-30) — Purchase Of Intangibles: -3506000.00
MME.AX cash_flow (annual, 2022-06-30) — Purchase Of Investment: -14524000.00
MME.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -349000.00
MME.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 115982000.00
MME.AX balance_sheet (annual, 2022-06-30) — Receivables: 1263788000.00
MME.AX balance_sheet (annual, 2022-06-30) — Receivables Adjustments Allowances: -81488000.00
MME.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 2239000.00
MME.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -56308000.00
MME.AX income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 22029000.00
MME.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 50191000.00
MME.AX balance_sheet (annual, 2022-06-30) — Share Issued: 235847226.00
MME.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 91276000.00
MME.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: -8287000.00
MME.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
MME.AX income_statement (annual, 2022-06-30) — Tax Provision: 2582000.00
MME.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.30
MME.AX balance_sheet (annual, 2022-06-30) — Total Assets: 1480466000.00
MME.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 1449547000.00
MME.AX balance_sheet (annual, 2022-06-30) — Total Debt: 1360933000.00
MME.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 91276000.00
MME.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 1380518000.00
MME.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 125504000.00
MME.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 1359895000.00
MME.AX income_statement (annual, 2022-06-30) — Total Other Finance Cost: 90000.00
MME.AX balance_sheet (annual, 2022-06-30) — Working Capital: 1334339000.00
MME.AX income_statement (annual, 2023-06-30) — +Operating Expense: 136786000.00
MME.AX income_statement (annual, 2023-06-30) — +Total Revenue: 229659000.00
MME.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 1149646000.00
MME.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -2958000.00
MME.AX income_statement (annual, 2023-06-30) — Amortization: 9516000.00
MME.AX income_statement (annual, 2023-06-30) — Amortization Of Intangibles Income Statement: 9516000.00
MME.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 321359863.00
MME.AX income_statement (annual, 2023-06-30) — Basic EPS: 0.04
MME.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 80675000.00
MME.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -8564000.00
MME.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 3117000.00
MME.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 203428000.00
MME.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 91714000.00
MME.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 91714000.00
MME.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 91714000.00
MME.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: -188783000.00
MME.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -8564000.00
MME.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: 208386000.00
MME.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 11039000.00
MME.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -62168000.00
MME.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 353770000.00
MME.AX balance_sheet (annual, 2023-06-30) — Common Stock: 203428000.00
MME.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 166063000.00
MME.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 62546000.00
MME.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -2087000.00
MME.AX balance_sheet (annual, 2023-06-30) — Current Assets: 1173301000.00
MME.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 6199000.00
MME.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 11340000.00
MME.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 11340000.00
MME.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 1824000.00
MME.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 321359863.00
MME.AX income_statement (annual, 2023-06-30) — Diluted EPS: 0.04
MME.AX income_statement (annual, 2023-06-30) — EBIT: 101919000.00
MME.AX income_statement (annual, 2023-06-30) — EBITDA: 113259000.00
MME.AX balance_sheet (annual, 2023-06-30) — Employee Benefits: 2425000.00
MME.AX cash_flow (annual, 2023-06-30) — End Cash Position: 91714000.00
MME.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: -188783000.00
MME.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: 199822000.00
MME.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 6657000.00
MME.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 35488000.00
MME.AX balance_sheet (annual, 2023-06-30) — Goodwill: 63510000.00
MME.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 96267000.00
MME.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 9001000.00
MME.AX income_statement (annual, 2023-06-30) — Gross Profit: 229659000.00
MME.AX balance_sheet (annual, 2023-06-30) — Hedging Assets Current: 7934000.00
MME.AX cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: -13000.00
MME.AX income_statement (annual, 2023-06-30) — Interest Expense: 89633000.00
MME.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 89633000.00
MME.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -83229000.00
MME.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 83229000.00
MME.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 1281484000.00
MME.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -8564000.00
MME.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 62546000.00
MME.AX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 3117000.00
MME.AX balance_sheet (annual, 2023-06-30) — Long Term Debt: 1115421000.00
MME.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 1118538000.00
MME.AX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -244642000.00
MME.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 5102000.00
MME.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 60459000.00
MME.AX balance_sheet (annual, 2023-06-30) — Net Debt: 1023707000.00
MME.AX income_statement (annual, 2023-06-30) — Net Income: 12286000.00
MME.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 12286000.00
MME.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 12286000.00
MME.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 12286000.00
MME.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 12286000.00
MME.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 12286000.00
MME.AX cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: -5977000.00
MME.AX income_statement (annual, 2023-06-30) — Net Interest Income: -89805000.00
MME.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -244642000.00
MME.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -244642000.00
MME.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -89805000.00
MME.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -5716000.00
MME.AX balance_sheet (annual, 2023-06-30) — Net PPE: 6043000.00
MME.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -2587000.00
MME.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 69796000.00
MME.AX balance_sheet (annual, 2023-06-30) — Non Current Accounts Receivable: 14422000.00
MME.AX balance_sheet (annual, 2023-06-30) — Non Current Deferred Assets: 3192000.00
MME.AX balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Assets: 3192000.00
MME.AX balance_sheet (annual, 2023-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 2425000.00
MME.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: 113259000.00
MME.AX income_statement (annual, 2023-06-30) — Normalized Income: 12286000.00
MME.AX income_statement (annual, 2023-06-30) — Operating Income: 92873000.00
MME.AX income_statement (annual, 2023-06-30) — Operating Revenue: 229659000.00
MME.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 800078476.00
MME.AX cash_flow (annual, 2023-06-30) — Other Cash Receiptsfrom Operating Activities: 31709000.00
MME.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 6657000.00
MME.AX income_statement (annual, 2023-06-30) — Other Gand A: 35488000.00
MME.AX income_statement (annual, 2023-06-30) — Other Income Expense: 9218000.00
MME.AX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 32757000.00
MME.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 9218000.00
MME.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 14509000.00
MME.AX balance_sheet (annual, 2023-06-30) — Other Payable: 6199000.00
MME.AX balance_sheet (annual, 2023-06-30) — Other Properties: 3899000.00
MME.AX balance_sheet (annual, 2023-06-30) — Payables: 6199000.00
MME.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 6199000.00
MME.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -62168000.00
MME.AX income_statement (annual, 2023-06-30) — Pretax Income: 12286000.00
MME.AX income_statement (annual, 2023-06-30) — Provision For Doubtful Accounts: 67543000.00
MME.AX cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: -5977000.00
MME.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -2587000.00
MME.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Customers: 322061000.00
MME.AX balance_sheet (annual, 2023-06-30) — Receivables: 1073653000.00
MME.AX balance_sheet (annual, 2023-06-30) — Receivables Adjustments Allowances: -75993000.00
MME.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 11340000.00
MME.AX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -244642000.00
MME.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -2087000.00
MME.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -44022000.00
MME.AX income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 7906000.00
MME.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 43394000.00
MME.AX balance_sheet (annual, 2023-06-30) — Share Issued: 800078476.00
MME.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 166063000.00
MME.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 69796000.00
MME.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
MME.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
MME.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
MME.AX cash_flow (annual, 2023-06-30) — Taxes Refund Paid Direct: 13000.00
MME.AX balance_sheet (annual, 2023-06-30) — Total Assets: 1293225000.00
MME.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 1281484000.00
MME.AX balance_sheet (annual, 2023-06-30) — Total Debt: 1118538000.00
MME.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 166063000.00
MME.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 1127162000.00
MME.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 119924000.00
MME.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 1120963000.00
MME.AX income_statement (annual, 2023-06-30) — Total Other Finance Cost: 172000.00
MME.AX balance_sheet (annual, 2023-06-30) — Working Capital: 1167102000.00
MME.AX income_statement (annual, 2024-06-30) — +Operating Expense: 103287000.00
MME.AX income_statement (annual, 2024-06-30) — +Total Revenue: 207128000.00
MME.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 1218591000.00
MME.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -2996000.00
MME.AX income_statement (annual, 2024-06-30) — Amortization: 8850000.00
MME.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 8850000.00
MME.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 795078476.00
MME.AX income_statement (annual, 2024-06-30) — Basic EPS: 0.03
MME.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 91714000.00
MME.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -4910000.00
MME.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 2176000.00
MME.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 203428000.00
MME.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 73630000.00
MME.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 73630000.00
MME.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 73630000.00
MME.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 37606000.00
MME.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -4910000.00
MME.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -50780000.00
MME.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -18084000.00
MME.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -67018000.00
MME.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 98812000.00
MME.AX balance_sheet (annual, 2024-06-30) — Common Stock: 203428000.00
MME.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 189888000.00
MME.AX balance_sheet (annual, 2024-06-30) — Current Assets: 1238025000.00
MME.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 5953000.00
MME.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 10946000.00
MME.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 10946000.00
MME.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 2096000.00
MME.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 795078476.00
MME.AX income_statement (annual, 2024-06-30) — Diluted EPS: 0.03
MME.AX income_statement (annual, 2024-06-30) — EBIT: 110635000.00
MME.AX income_statement (annual, 2024-06-30) — EBITDA: 121581000.00
MME.AX balance_sheet (annual, 2024-06-30) — Employee Benefits: 2775000.00
MME.AX cash_flow (annual, 2024-06-30) — End Cash Position: 73630000.00
MME.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 37606000.00
MME.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -55690000.00
MME.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 7757000.00
MME.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 36424000.00
MME.AX balance_sheet (annual, 2024-06-30) — Goodwill: 63510000.00
MME.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 92340000.00
MME.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 7123000.00
MME.AX income_statement (annual, 2024-06-30) — Gross Profit: 207128000.00
MME.AX balance_sheet (annual, 2024-06-30) — Hedging Assets Current: 2596000.00
MME.AX income_statement (annual, 2024-06-30) — Interest Expense: 98248000.00
MME.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 98248000.00
MME.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: -82574000.00
MME.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 82574000.00
MME.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 1356599000.00
MME.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -4910000.00
MME.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 42655000.00
MME.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 2176000.00
MME.AX balance_sheet (annual, 2024-06-30) — Long Term Debt: 1166711000.00
MME.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 1168887000.00
MME.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 42655000.00
MME.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 5176000.00
MME.AX balance_sheet (annual, 2024-06-30) — Net Debt: 1093081000.00
MME.AX income_statement (annual, 2024-06-30) — Net Income: 22725000.00
MME.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 22725000.00
MME.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 22725000.00
MME.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 22725000.00
MME.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 22725000.00
MME.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 22725000.00
MME.AX cash_flow (annual, 2024-06-30) — Net Intangibles Purchase And Sale: -4838000.00
MME.AX income_statement (annual, 2024-06-30) — Net Interest Income: -98472000.00
MME.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 42655000.00
MME.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 42655000.00
MME.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -98472000.00
MME.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -6306000.00
MME.AX balance_sheet (annual, 2024-06-30) — Net PPE: 4127000.00
MME.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -72000.00
MME.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 97548000.00
MME.AX balance_sheet (annual, 2024-06-30) — Non Current Accounts Receivable: 19481000.00
MME.AX balance_sheet (annual, 2024-06-30) — Non Current Deferred Assets: 13530000.00
MME.AX balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Assets: 13530000.00
MME.AX balance_sheet (annual, 2024-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 2775000.00
MME.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: 121581000.00
MME.AX income_statement (annual, 2024-06-30) — Normalized Income: 22725000.00
MME.AX income_statement (annual, 2024-06-30) — Operating Income: 103841000.00
MME.AX income_statement (annual, 2024-06-30) — Operating Revenue: 207128000.00
MME.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 795078476.00
MME.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: -83882000.00
MME.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 7757000.00
MME.AX income_statement (annual, 2024-06-30) — Other Gand A: 36424000.00
MME.AX income_statement (annual, 2024-06-30) — Other Income Expense: 7018000.00
MME.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 28830000.00
MME.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 7018000.00
MME.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 14527000.00
MME.AX balance_sheet (annual, 2024-06-30) — Other Payable: 5953000.00
MME.AX balance_sheet (annual, 2024-06-30) — Other Properties: 1947000.00
MME.AX balance_sheet (annual, 2024-06-30) — Payables: 5953000.00
MME.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 5953000.00
MME.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -67018000.00
MME.AX income_statement (annual, 2024-06-30) — Pretax Income: 12387000.00
MME.AX income_statement (annual, 2024-06-30) — Provision For Doubtful Accounts: 34385000.00
MME.AX cash_flow (annual, 2024-06-30) — Purchase Of Intangibles: -4838000.00
MME.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -72000.00
MME.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Customers: 182694000.00
MME.AX balance_sheet (annual, 2024-06-30) — Receivables: 1161799000.00
MME.AX balance_sheet (annual, 2024-06-30) — Receivables Adjustments Allowances: -56792000.00
MME.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 10946000.00
MME.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -21297000.00
MME.AX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 7005000.00
MME.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 43429000.00
MME.AX balance_sheet (annual, 2024-06-30) — Share Issued: 795078476.00
MME.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 189888000.00
MME.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 97548000.00
MME.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
MME.AX income_statement (annual, 2024-06-30) — Tax Provision: -10338000.00
MME.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.30
MME.AX balance_sheet (annual, 2024-06-30) — Total Assets: 1367503000.00
MME.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 1356599000.00
MME.AX balance_sheet (annual, 2024-06-30) — Total Debt: 1168887000.00
MME.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 189888000.00
MME.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 1177615000.00
MME.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 129478000.00
MME.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 1171662000.00
MME.AX income_statement (annual, 2024-06-30) — Total Other Finance Cost: 224000.00
MME.AX balance_sheet (annual, 2024-06-30) — Working Capital: 1232072000.00
MMED income_statement (annual, 2023-04-30) — +Operating Expense: 1377000000.00
MMED income_statement (annual, 2023-04-30) — +Total Revenue: 2245000000.00
MMED cash_flow (annual, 2023-04-30) — Amortization Cash Flow: 33000000.00
MMED cash_flow (annual, 2023-04-30) — Amortization Of Intangibles: 33000000.00
MMED income_statement (annual, 2023-04-30) — Basic Average Shares: 280813348.00
MMED income_statement (annual, 2023-04-30) — Basic EPS: -0.34
MMED cash_flow (annual, 2023-04-30) — Beginning Cash Position: 60000000.00
MMED cash_flow (annual, 2023-04-30) — Capital Expenditure: -167000000.00
MMED cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Financing Activities: 185000000.00
MMED cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Investing Activities: -180000000.00
MMED cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Operating Activities: -4000000.00
MMED cash_flow (annual, 2023-04-30) — Change In Account Payable: 14000000.00
MMED cash_flow (annual, 2023-04-30) — Change In Inventory: -28000000.00
MMED cash_flow (annual, 2023-04-30) — Change In Other Working Capital: -6000000.00
MMED cash_flow (annual, 2023-04-30) — Change In Payable: 14000000.00
MMED cash_flow (annual, 2023-04-30) — Change In Payables And Accrued Expense: 14000000.00
MMED cash_flow (annual, 2023-04-30) — Change In Receivables: -70000000.00
MMED cash_flow (annual, 2023-04-30) — Change In Working Capital: -90000000.00
MMED cash_flow (annual, 2023-04-30) — Changes In Account Receivables: -70000000.00
MMED cash_flow (annual, 2023-04-30) — Changes In Cash: -2000000.00
MMED income_statement (annual, 2023-04-30) — Cost Of Revenue: 937000000.00
MMED cash_flow (annual, 2023-04-30) — Deferred Income Tax: -11000000.00
MMED cash_flow (annual, 2023-04-30) — Deferred Tax: -11000000.00
MMED cash_flow (annual, 2023-04-30) — Depreciation: 82000000.00
MMED cash_flow (annual, 2023-04-30) — Depreciation Amortization Depletion: 115000000.00
MMED cash_flow (annual, 2023-04-30) — Depreciation And Amortization: 115000000.00
MMED income_statement (annual, 2023-04-30) — Diluted Average Shares: 280813348.00
MMED income_statement (annual, 2023-04-30) — Diluted EPS: -0.34
MMED income_statement (annual, 2023-04-30) — Diluted NI Availto Com Stockholders: -96000000.00
MMED income_statement (annual, 2023-04-30) — EBIT: -69000000.00
MMED income_statement (annual, 2023-04-30) — EBITDA: 46000000.00
MMED cash_flow (annual, 2023-04-30) — End Cash Position: 58000000.00
MMED cash_flow (annual, 2023-04-30) — Financing Cash Flow: 185000000.00
MMED cash_flow (annual, 2023-04-30) — Free Cash Flow: -173000000.00
MMED income_statement (annual, 2023-04-30) — Gross Profit: 1308000000.00
MMED cash_flow (annual, 2023-04-30) — Investing Cash Flow: -180000000.00
MMED income_statement (annual, 2023-04-30) — Minority Interests: -5000000.00
MMED income_statement (annual, 2023-04-30) — Net Income: -96000000.00
MMED income_statement (annual, 2023-04-30) — Net Income Common Stockholders: -96000000.00
MMED income_statement (annual, 2023-04-30) — Net Income Continuous Operations: -92000000.00
MMED income_statement (annual, 2023-04-30) — Net Income From Continuing And Discontinued Operation: -96000000.00
MMED income_statement (annual, 2023-04-30) — Net Income From Continuing Operation Net Minority Interest: -96000000.00
MMED cash_flow (annual, 2023-04-30) — Net Income From Continuing Operations: -92000000.00
MMED income_statement (annual, 2023-04-30) — Net Income Including Noncontrolling Interests: -92000000.00
MMED cash_flow (annual, 2023-04-30) — Net Investment Purchase And Sale: -13000000.00
MMED cash_flow (annual, 2023-04-30) — Net Other Financing Charges: 185000000.00
MMED cash_flow (annual, 2023-04-30) — Net PPE Purchase And Sale: -167000000.00
MMED income_statement (annual, 2023-04-30) — Normalized EBITDA: 46000000.00
MMED income_statement (annual, 2023-04-30) — Normalized Income: -96000000.00
MMED cash_flow (annual, 2023-04-30) — Operating Cash Flow: -6000000.00
MMED cash_flow (annual, 2023-04-30) — Operating Gains Losses: 10000000.00
MMED income_statement (annual, 2023-04-30) — Operating Income: -69000000.00
MMED income_statement (annual, 2023-04-30) — Operating Revenue: 2245000000.00
MMED income_statement (annual, 2023-04-30) — Other Income Expense: -7000000.00
MMED cash_flow (annual, 2023-04-30) — Other Non Cash Items: 12000000.00
MMED income_statement (annual, 2023-04-30) — Other Non Operating Income Expenses: -7000000.00
MMED income_statement (annual, 2023-04-30) — Other Operating Expenses: -12000000.00
MMED cash_flow (annual, 2023-04-30) — Pension And Employee Benefit Expense: 10000000.00
MMED income_statement (annual, 2023-04-30) — Pretax Income: -76000000.00
MMED cash_flow (annual, 2023-04-30) — Provisionand Write Offof Assets: 15000000.00
MMED cash_flow (annual, 2023-04-30) — Purchase Of Investment: -13000000.00
MMED cash_flow (annual, 2023-04-30) — Purchase Of PPE: -167000000.00
MMED income_statement (annual, 2023-04-30) — Reconciled Cost Of Revenue: 937000000.00
MMED income_statement (annual, 2023-04-30) — Reconciled Depreciation: 115000000.00
MMED income_statement (annual, 2023-04-30) — Research And Development: 429000000.00
MMED cash_flow (annual, 2023-04-30) — Sale Of Investment: 0.00
MMED income_statement (annual, 2023-04-30) — Selling And Marketing Expense: 960000000.00
MMED income_statement (annual, 2023-04-30) — Selling General And Administration: 960000000.00
MMED income_statement (annual, 2023-04-30) — Special Income Charges: 0.00
MMED cash_flow (annual, 2023-04-30) — Stock Based Compensation: 35000000.00
MMED income_statement (annual, 2023-04-30) — Tax Effect Of Unusual Items: 0.00
MMED income_statement (annual, 2023-04-30) — Tax Provision: 16000000.00
MMED income_statement (annual, 2023-04-30) — Tax Rate For Calcs: 0.21
MMED income_statement (annual, 2023-04-30) — Total Expenses: 2314000000.00
MMED income_statement (annual, 2023-04-30) — Total Operating Income As Reported: -69000000.00
MMED income_statement (annual, 2023-04-30) — Total Unusual Items: 0.00
MMED income_statement (annual, 2023-04-30) — Total Unusual Items Excluding Goodwill: 0.00
MMED income_statement (annual, 2024-04-30) — +Operating Expense: 1497000000.00
MMED income_statement (annual, 2024-04-30) — +Total Revenue: 2469000000.00
MMED balance_sheet (annual, 2024-04-30) — Accounts Payable: 190000000.00
MMED balance_sheet (annual, 2024-04-30) — Accounts Receivable: 507000000.00
MMED balance_sheet (annual, 2024-04-30) — Accumulated Depreciation: -556000000.00
MMED balance_sheet (annual, 2024-04-30) — Allowance For Doubtful Accounts Receivable: -40000000.00
MMED cash_flow (annual, 2024-04-30) — Amortization Cash Flow: 33000000.00
MMED cash_flow (annual, 2024-04-30) — Amortization Of Intangibles: 33000000.00
MMED cash_flow (annual, 2024-04-30) — Asset Impairment Charge: 0.00
MMED income_statement (annual, 2024-04-30) — Basic Average Shares: 280813348.00
MMED income_statement (annual, 2024-04-30) — Basic EPS: -0.40
MMED cash_flow (annual, 2024-04-30) — Beginning Cash Position: 58000000.00
MMED balance_sheet (annual, 2024-04-30) — Buildings And Improvements: 214000000.00
MMED cash_flow (annual, 2024-04-30) — Capital Expenditure: -148000000.00
MMED balance_sheet (annual, 2024-04-30) — Capital Lease Obligations: 8000000.00
MMED balance_sheet (annual, 2024-04-30) — Cash And Cash Equivalents: 54000000.00
MMED balance_sheet (annual, 2024-04-30) — Cash Cash Equivalents And Short Term Investments: 54000000.00
MMED cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Financing Activities: 112000000.00
MMED cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Investing Activities: -156000000.00
MMED cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Operating Activities: 40000000.00
MMED cash_flow (annual, 2024-04-30) — Change In Account Payable: -4000000.00
MMED cash_flow (annual, 2024-04-30) — Change In Inventory: 5000000.00
MMED cash_flow (annual, 2024-04-30) — Change In Other Current Liabilities: 0.00
MMED cash_flow (annual, 2024-04-30) — Change In Other Working Capital: 30000000.00
MMED cash_flow (annual, 2024-04-30) — Change In Payable: -4000000.00
MMED cash_flow (annual, 2024-04-30) — Change In Payables And Accrued Expense: -4000000.00
MMED cash_flow (annual, 2024-04-30) — Change In Receivables: -105000000.00
MMED cash_flow (annual, 2024-04-30) — Change In Working Capital: -74000000.00
MMED cash_flow (annual, 2024-04-30) — Changes In Account Receivables: -105000000.00
MMED cash_flow (annual, 2024-04-30) — Changes In Cash: -4000000.00
MMED balance_sheet (annual, 2024-04-30) — Common Stock Equity: 3448000000.00
MMED cash_flow (annual, 2024-04-30) — Common Stock Issuance: 0.00
MMED balance_sheet (annual, 2024-04-30) — Construction In Progress: 294000000.00
MMED income_statement (annual, 2024-04-30) — Cost Of Revenue: 1032000000.00
MMED balance_sheet (annual, 2024-04-30) — Current Accrued Expenses: 141000000.00
MMED balance_sheet (annual, 2024-04-30) — Current Assets: 895000000.00
MMED balance_sheet (annual, 2024-04-30) — Current Capital Lease Obligation: 8000000.00
MMED balance_sheet (annual, 2024-04-30) — Current Debt And Capital Lease Obligation: 8000000.00
MMED balance_sheet (annual, 2024-04-30) — Current Deferred Liabilities: 11000000.00
MMED balance_sheet (annual, 2024-04-30) — Current Deferred Revenue: 11000000.00
MMED balance_sheet (annual, 2024-04-30) — Current Liabilities: 518000000.00
MMED cash_flow (annual, 2024-04-30) — Deferred Income Tax: 3000000.00
MMED cash_flow (annual, 2024-04-30) — Deferred Tax: 3000000.00
MMED cash_flow (annual, 2024-04-30) — Depreciation: 96000000.00
MMED cash_flow (annual, 2024-04-30) — Depreciation Amortization Depletion: 129000000.00
MMED cash_flow (annual, 2024-04-30) — Depreciation And Amortization: 129000000.00
MMED income_statement (annual, 2024-04-30) — Diluted Average Shares: 280813348.00
MMED income_statement (annual, 2024-04-30) — Diluted EPS: -0.40
MMED income_statement (annual, 2024-04-30) — Diluted NI Availto Com Stockholders: -112000000.00
MMED income_statement (annual, 2024-04-30) — EBIT: -61000000.00
MMED income_statement (annual, 2024-04-30) — EBITDA: 68000000.00
MMED cash_flow (annual, 2024-04-30) — Effect Of Exchange Rate Changes: 0.00
MMED cash_flow (annual, 2024-04-30) — End Cash Position: 54000000.00
MMED cash_flow (annual, 2024-04-30) — Financing Cash Flow: 112000000.00
MMED balance_sheet (annual, 2024-04-30) — Finished Goods: 165000000.00
MMED cash_flow (annual, 2024-04-30) — Free Cash Flow: -107000000.00
MMED balance_sheet (annual, 2024-04-30) — Gains Losses Not Affecting Retained Earnings: -16000000.00
MMED balance_sheet (annual, 2024-04-30) — Goodwill: 2255000000.00
MMED balance_sheet (annual, 2024-04-30) — Goodwill And Other Intangible Assets: 2415000000.00
MMED balance_sheet (annual, 2024-04-30) — Gross Accounts Receivable: 547000000.00
MMED balance_sheet (annual, 2024-04-30) — Gross PPE: 1192000000.00
MMED income_statement (annual, 2024-04-30) — Gross Profit: 1436000000.00
MMED cash_flow (annual, 2024-04-30) — Income Tax Paid Supplemental Data: 0.00
MMED balance_sheet (annual, 2024-04-30) — Inventory: 292000000.00
MMED balance_sheet (annual, 2024-04-30) — Invested Capital: 3448000000.00
MMED cash_flow (annual, 2024-04-30) — Investing Cash Flow: -157000000.00
MMED cash_flow (annual, 2024-04-30) — Issuance Of Capital Stock: 0.00
MMED balance_sheet (annual, 2024-04-30) — Land And Improvements: 7000000.00
MMED balance_sheet (annual, 2024-04-30) — Machinery Furniture Equipment: 334000000.00
MMED income_statement (annual, 2024-04-30) — Minority Interests: -5000000.00
MMED cash_flow (annual, 2024-04-30) — Net Common Stock Issuance: 0.00
MMED income_statement (annual, 2024-04-30) — Net Income: -112000000.00
MMED income_statement (annual, 2024-04-30) — Net Income Common Stockholders: -112000000.00
MMED income_statement (annual, 2024-04-30) — Net Income Continuous Operations: -108000000.00
MMED income_statement (annual, 2024-04-30) — Net Income From Continuing And Discontinued Operation: -112000000.00
MMED income_statement (annual, 2024-04-30) — Net Income From Continuing Operation Net Minority Interest: -112000000.00
MMED cash_flow (annual, 2024-04-30) — Net Income From Continuing Operations: -107000000.00
MMED income_statement (annual, 2024-04-30) — Net Income Including Noncontrolling Interests: -107000000.00
MMED cash_flow (annual, 2024-04-30) — Net Investment Purchase And Sale: 6000000.00
MMED cash_flow (annual, 2024-04-30) — Net Other Financing Charges: 112000000.00
MMED cash_flow (annual, 2024-04-30) — Net Other Investing Changes: -15000000.00
MMED balance_sheet (annual, 2024-04-30) — Net PPE: 636000000.00
MMED cash_flow (annual, 2024-04-30) — Net PPE Purchase And Sale: -148000000.00
MMED balance_sheet (annual, 2024-04-30) — Net Tangible Assets: 1033000000.00
MMED balance_sheet (annual, 2024-04-30) — Non Current Accounts Receivable: 16000000.00
MMED income_statement (annual, 2024-04-30) — Normalized EBITDA: 76000000.00
MMED income_statement (annual, 2024-04-30) — Normalized Income: -105680000.00
MMED cash_flow (annual, 2024-04-30) — Operating Cash Flow: 41000000.00
MMED cash_flow (annual, 2024-04-30) — Operating Gains Losses: 8000000.00
MMED income_statement (annual, 2024-04-30) — Operating Income: -61000000.00
MMED income_statement (annual, 2024-04-30) — Operating Revenue: 2469000000.00
MMED balance_sheet (annual, 2024-04-30) — Ordinary Shares Number: 280813348.00
MMED balance_sheet (annual, 2024-04-30) — Other Current Assets: 42000000.00
MMED balance_sheet (annual, 2024-04-30) — Other Current Liabilities: -1000000.00
MMED balance_sheet (annual, 2024-04-30) — Other Equity Adjustments: -16000000.00
MMED balance_sheet (annual, 2024-04-30) — Other Equity Interest: 3464000000.00
MMED income_statement (annual, 2024-04-30) — Other Income Expense: -9000000.00
MMED balance_sheet (annual, 2024-04-30) — Other Intangible Assets: 160000000.00
MMED cash_flow (annual, 2024-04-30) — Other Non Cash Items: 22000000.00
MMED balance_sheet (annual, 2024-04-30) — Other Non Current Assets: 131000000.00
MMED balance_sheet (annual, 2024-04-30) — Other Non Current Liabilities: 128000000.00
MMED income_statement (annual, 2024-04-30) — Other Non Operating Income Expenses: -1000000.00
MMED income_statement (annual, 2024-04-30) — Other Operating Expenses: 3000000.00
MMED balance_sheet (annual, 2024-04-30) — Other Properties: 343000000.00
MMED balance_sheet (annual, 2024-04-30) — Payables: 190000000.00
MMED balance_sheet (annual, 2024-04-30) — Payables And Accrued Expenses: 331000000.00
MMED cash_flow (annual, 2024-04-30) — Pension And Employee Benefit Expense: 8000000.00
MMED balance_sheet (annual, 2024-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 169000000.00
MMED income_statement (annual, 2024-04-30) — Pretax Income: -70000000.00
MMED balance_sheet (annual, 2024-04-30) — Properties: 0.00
MMED cash_flow (annual, 2024-04-30) — Provisionand Write Offof Assets: 22000000.00
MMED cash_flow (annual, 2024-04-30) — Purchase Of Investment: -5000000.00
MMED cash_flow (annual, 2024-04-30) — Purchase Of PPE: -148000000.00
MMED balance_sheet (annual, 2024-04-30) — Raw Materials: 99000000.00
MMED balance_sheet (annual, 2024-04-30) — Receivables: 507000000.00
MMED income_statement (annual, 2024-04-30) — Reconciled Cost Of Revenue: 1032000000.00
MMED income_statement (annual, 2024-04-30) — Reconciled Depreciation: 129000000.00
MMED income_statement (annual, 2024-04-30) — Research And Development: 437000000.00
MMED income_statement (annual, 2024-04-30) — Restructuring And Mergern Acquisition: 8000000.00
MMED cash_flow (annual, 2024-04-30) — Sale Of Investment: 11000000.00
MMED income_statement (annual, 2024-04-30) — Selling And Marketing Expense: 1057000000.00
MMED income_statement (annual, 2024-04-30) — Selling General And Administration: 1057000000.00
MMED balance_sheet (annual, 2024-04-30) — Share Issued: 280813348.00
MMED income_statement (annual, 2024-04-30) — Special Income Charges: -8000000.00
MMED cash_flow (annual, 2024-04-30) — Stock Based Compensation: 38000000.00
MMED balance_sheet (annual, 2024-04-30) — Stockholders Equity: 3448000000.00
MMED balance_sheet (annual, 2024-04-30) — Tangible Book Value: 1033000000.00
MMED income_statement (annual, 2024-04-30) — Tax Effect Of Unusual Items: -1680000.00
MMED income_statement (annual, 2024-04-30) — Tax Provision: 38000000.00
MMED income_statement (annual, 2024-04-30) — Tax Rate For Calcs: 0.21
MMED balance_sheet (annual, 2024-04-30) — Total Assets: 4094000000.00
MMED balance_sheet (annual, 2024-04-30) — Total Capitalization: 3448000000.00
MMED balance_sheet (annual, 2024-04-30) — Total Debt: 8000000.00
MMED balance_sheet (annual, 2024-04-30) — Total Equity Gross Minority Interest: 3448000000.00
MMED income_statement (annual, 2024-04-30) — Total Expenses: 2529000000.00
MMED balance_sheet (annual, 2024-04-30) — Total Liabilities Net Minority Interest: 646000000.00
MMED balance_sheet (annual, 2024-04-30) — Total Non Current Assets: 3198000000.00
MMED balance_sheet (annual, 2024-04-30) — Total Non Current Liabilities Net Minority Interest: 128000000.00
MMED income_statement (annual, 2024-04-30) — Total Operating Income As Reported: -69000000.00
MMED income_statement (annual, 2024-04-30) — Total Unusual Items: -8000000.00
MMED income_statement (annual, 2024-04-30) — Total Unusual Items Excluding Goodwill: -8000000.00
MMED balance_sheet (annual, 2024-04-30) — Work In Process: 28000000.00
MMED balance_sheet (annual, 2024-04-30) — Working Capital: 377000000.00
MMED income_statement (quarterly, 2025-01-31) — +Operating Expense: 373000000.00
MMED income_statement (quarterly, 2025-01-31) — +Total Revenue: 687000000.00
MMED income_statement (quarterly, 2025-01-31) — Basic Average Shares: 280813348.00
MMED income_statement (quarterly, 2025-01-31) — Basic EPS: -0.04
MMED cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 10000000.00
MMED cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -50000000.00
MMED cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 26000000.00
MMED cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -50000000.00
MMED cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: 24000000.00
MMED cash_flow (quarterly, 2025-01-31) — Change In Account Payable: 35000000.00
MMED cash_flow (quarterly, 2025-01-31) — Change In Inventory: -26000000.00
MMED cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: -13000000.00
MMED cash_flow (quarterly, 2025-01-31) — Change In Payable: 35000000.00
MMED cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: 35000000.00
MMED cash_flow (quarterly, 2025-01-31) — Change In Receivables: -20000000.00
MMED cash_flow (quarterly, 2025-01-31) — Change In Working Capital: -24000000.00
MMED cash_flow (quarterly, 2025-01-31) — Changes In Account Receivables: -20000000.00
MMED cash_flow (quarterly, 2025-01-31) — Changes In Cash: 0.00
MMED income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 292000000.00
MMED cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 37000000.00
MMED cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 37000000.00
MMED income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 280813348.00
MMED income_statement (quarterly, 2025-01-31) — Diluted EPS: -0.04
MMED income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -10000000.00
MMED income_statement (quarterly, 2025-01-31) — EBIT: 22000000.00
MMED income_statement (quarterly, 2025-01-31) — EBITDA: 59000000.00
MMED cash_flow (quarterly, 2025-01-31) — End Cash Position: 10000000.00
MMED cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 25000000.00
MMED cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -26000000.00
MMED income_statement (quarterly, 2025-01-31) — Gross Profit: 395000000.00
MMED cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -50000000.00
MMED income_statement (quarterly, 2025-01-31) — Minority Interests: -3000000.00
MMED income_statement (quarterly, 2025-01-31) — Net Income: -10000000.00
MMED income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -10000000.00
MMED income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -7000000.00
MMED income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -10000000.00